AHA's public policies are generally robust and well aligned with its 2020 CVH metrics and CVD indicators, though gaps exist in age-specific policies and quantitative targets for CVD management.
No takes yet. Share an insight, caveat, or question.
AHA policies align with CVH metrics but evidence gaps limit confidence; leaves open targeted research on implementation and quantitative targets.
Labarthe et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: